257 336

Cited 457 times in

Preventing ventricular fibrillation by flattening cardiac restitution

DC Field Value Language
dc.contributor.author이문형-
dc.date.accessioned2019-11-11T05:23:54Z-
dc.date.available2019-11-11T05:23:54Z-
dc.date.issued2000-
dc.identifier.issn0027-8424-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171844-
dc.description.abstractVentricular fibrillation is the leading cause of sudden cardiac death. In fibrillation, fragmented electrical waves meander erratically through the heart muscle, creating disordered and ineffective contraction. Theoretical and computer studies, as well as recent experimental evidence, have suggested that fibrillation is created and sustained by the property of restitution of the cardiac action potential duration (that is, its dependence on the previous diastolic interval). The restitution hypothesis states that steeply sloped restitution curves create unstable wave propagation that results in wave break, the event that is necessary for fibrillation. Here we present experimental evidence supporting this idea. In particular, we identify the action of the drug bretylium as a prototype for the future development of effective restitution-based antifibrillatory agents. We show that bretylium acts in accord with the restitution hypothesis: by flattening restitution curves, it prevents wave break and thus prevents fibrillation. It even converts existing fibrillation, either to a periodic state (ventricular tachycardia, which is much more easily controlled) or to quiescent healthy tissue.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherNational Academy of Sciences-
dc.relation.isPartOfProceedings of the National Academy of Sciences of the United States of America-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAction Potentials/drug effects-
dc.subject.MESHAnimals-
dc.subject.MESHAnti-Arrhythmia Agents/pharmacology-
dc.subject.MESHAnti-Arrhythmia Agents/therapeutic use*-
dc.subject.MESHBretylium Compounds/pharmacology-
dc.subject.MESHBretylium Compounds/therapeutic use*-
dc.subject.MESHCardiac Pacing, Artificial-
dc.subject.MESHComputer Simulation-
dc.subject.MESHCromakalim/pharmacology-
dc.subject.MESHCromakalim/therapeutic use-
dc.subject.MESHDiastole/physiology-
dc.subject.MESHDrug Design-
dc.subject.MESHDrug Evaluation, Preclinical-
dc.subject.MESHFluorescent Dyes-
dc.subject.MESHHeart Conduction System/drug effects*-
dc.subject.MESHHeart Conduction System/physiopathology-
dc.subject.MESHModels, Biological-
dc.subject.MESHPyridinium Compounds-
dc.subject.MESHSwine-
dc.subject.MESHVentricular Fibrillation/drug therapy-
dc.subject.MESHVentricular Fibrillation/physiopathology-
dc.subject.MESHVentricular Fibrillation/prevention & control*-
dc.titlePreventing ventricular fibrillation by flattening cardiac restitution-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorAlan Garfinkel-
dc.contributor.googleauthorYoung-Hoon Kim-
dc.contributor.googleauthorOlga Voroshilovsky-
dc.contributor.googleauthorZhilin Qu-
dc.contributor.googleauthorJong R. Kil-
dc.contributor.googleauthorMoon-Hyoung Lee-
dc.contributor.googleauthorHrayr S. Karagueuzian-
dc.contributor.googleauthorJames N. Weiss-
dc.contributor.googleauthorPeng-Sheng Chen-
dc.identifier.doi10.1073/pnas.090492697-
dc.contributor.localIdA02766-
dc.relation.journalcodeJ02550-
dc.identifier.eissn1091-6490-
dc.identifier.pmid10811880-
dc.contributor.alternativeNameLee, Moon Hyoung-
dc.contributor.affiliatedAuthor이문형-
dc.citation.volume97-
dc.citation.number11-
dc.citation.startPage6061-
dc.citation.endPage6066-
dc.identifier.bibliographicCitationProceedings of the National Academy of Sciences of the United States of America, Vol.97(11) : 6061-6066, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.